![Mahalakshmi Radhakrishnan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mahalakshmi Radhakrishnan
Directeur/Bestuurslid bij ENTRADA THERAPEUTICS, INC.
Vermogen: - $ op 30-11-2025
Profiel
Mahalakshmi Radhakrishnan bekleedt de functie van Chief Medical Officer & Group Senior VP bij Biogen, Inc. Dr. Radhakrishnan is tevens Senior Vice President & Head-Worldwide Medical bij Bioverativ Therapeutics, Inc. In haar vorige carrière bekleedde Dr. Radhakrishnan de functie van Vice President bij Biogen, Inc, Global Head-Medical & Primary Care Business Unit bij Sanofi en Executive Director & Head-Therapeutic Area bij Bristol-Myers Squibb Holdings Pharma LLC. Mahalakshmi Radhakrishnan promoveerde aan de Peoples' Friendship University van Rusland.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 04-06-2025 | 0 ( -.--% ) | - $ | 30-11-2025 | |
| 01-06-2025 | 0 ( -.--% ) | - $ | 30-11-2025 | |
| 17-03-2025 | 0 ( -.--% ) | - $ | 30-11-2025 |
Actieve functies van Mahalakshmi Radhakrishnan
| Bedrijven | Functie | Begin |
|---|---|---|
| ENTRADA THERAPEUTICS, INC. | Directeur/Bestuurslid | 01-06-2025 |
| CANDEL THERAPEUTICS, INC. | Directeur/Bestuurslid | 04-06-2025 |
PhRMA Foundation
 PhRMA Foundation Engages in research and development of drugs | Directeur/Bestuurslid | 29-11-2022 |
Minovia Therapeutics Ltd.
 Minovia Therapeutics Ltd. Develops mitochondrial cell therapies for clinical-stage biotechnology company | Directeur/Bestuurslid | 05-01-2023 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01-08-2024 |
Eerdere bekende functies van Mahalakshmi Radhakrishnan
| Bedrijven | Functie | Einde |
|---|---|---|
| ALTO NEUROSCIENCE, INC. | Directeur/Bestuurslid | 13-05-2025 |
| BIOGEN INC. | Hoofd Techniek/Wetenschap/O&O | 01-03-2024 |
| SANOFI | Corporate Officer/Principal | 01-01-2019 |
| BIOASIS TECHNOLOGIES INC. | Directeur/Bestuurslid | 27-07-2018 |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Opleiding van Mahalakshmi Radhakrishnan
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 12 |
|---|---|
Biogen, Inc.
 Biogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets therapies for neurological and neurodegenerative diseases | Health Technology |
Sanofi
 Sanofi Pharmaceuticals: MajorHealth Technology Engages in research, development and production of pharmaceuticals & vaccines | Health Technology |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Peoples' Friendship University of Russia
 Peoples' Friendship University of Russia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
biOasis Technologies, Inc.
 biOasis Technologies, Inc. BiotechnologyHealth Technology Engages in the development of diagnostics | Health Technology |
Bristol-Myers Squibb Holdings Pharma LLC
 Bristol-Myers Squibb Holdings Pharma LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
PhRMA Foundation
PhRMA Foundation Engages in research and development of drugs | |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. Develops and distributes immunotherapies for the treatment of cancer | |
Entrada Therapeutics, Inc.
 Entrada Therapeutics, Inc. Develops therapeutics for rare neuromuscular diseases | |
Minovia Therapeutics Ltd.
Minovia Therapeutics Ltd. Develops mitochondrial cell therapies for clinical-stage biotechnology company | |
Alto Neuroscience, Inc.
 Alto Neuroscience, Inc. Engages in psychiatric drug development |
